High sensitivity of embryonic stem cells to proteasome inhibitors correlates with low expression of heat shock

Jeong-A Park1, Young-Eun Kim, Yang-Hwa Ha

  • 1Department of Biochemistry, College of Natural Sciences, Chungbuk National University, Cheongju 361-763, Korea.

BMB Reports
|May 24, 2012
PubMed

Insights

Mouse embryonic stem cells show higher sensitivity to proteotoxic stress due to reduced heat shock protein 70 (HSP70) expression and declining pluripotent cell markers, impacting their survival.

Area of Science:

  • Cellular biology
  • Molecular biology
  • Stem cell research

Background:

  • The ubiquitin-proteasome system is crucial for cellular protein degradation.
  • Proteasome dysfunction can lead to proteotoxic stress and cellular damage.

Purpose of the Study:

  • To investigate the response of mouse embryonic stem (ES) cells to proteotoxic stress.
  • To understand the differential sensitivity of ES cells compared to somatic cells.

Main Methods:

  • Treatment of mouse ES cells and somatic cells with proteasome inhibitors.
  • Measurement of heat shock protein 70 (HSP70) expression.
  • Assessment of pluripotent cell marker expression (Oct4, Nanog).
  • Quantification of apoptosis.

Main Results:

  • Proteasome inhibitors induced HSP70 expression and apoptosis in ES cells in a dose- and time-dependent manner.
  • ES cells exhibited higher levels of apoptosis compared to somatic cells.
  • Somatic cells showed a more significant increase in HSP70 expression than ES cells.
  • Pluripotent markers Oct4 and Nanog decreased in ES cells under stress.

Conclusions:

  • ES cells are more sensitive to proteotoxic stress than somatic cells.
  • This sensitivity is linked to a lower capacity for HSP70 induction and reduced expression of essential pluripotent markers.
  • These factors are critical for ES cell survival under proteotoxic conditions.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.